Two Iranian families with a novel mutation in  GJB2  causing autosomal dominant nonsyndromic hearing loss by Bazazzadegan, Niloofar et al.
RESEARCH REVIEW
Two Iranian Families With a Novel Mutation in
GJB2 Causing Autosomal Dominant Nonsyndromic
Hearing Loss
Niloofar Bazazzadegan,1 Abraham M. Sheffield,2 Masoomeh Sobhani,3 Kimia Kahrizi,1 Nicole C. Meyer,2
Guy Van Camp,4 Nele Hilgert,4 Seyedeh Sedigheh Abedini,1 Farkhondeh Habibi,5 Ahmad Daneshi,6
Carla Nishimura,2 Matthew R. Avenarius,7 Mohammad Farhadi,6 Richard J.H. Smith,2
and Hossein Najmabadi1*
1Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
2Molecular Otolaryngology Research Laboratories, Department of Otolaryngology Head and Neck Surgery, University of Iowa, IA
3Prevention Department, Talesh Welfare Center, Gilan Province, Iran
4Department of Medical Genetics, University of Antwerp (UA), Antwerp, Belgium
5Prevention Department, Rasht Welfare Center, Gilan Province, Iran
6Research Center of Ear, Nose, Throat, Head and Neck Surgery, Iran University of Medical Sciences, Tehran, Iran
7Department of Human Genetics, University of Michigan School of Medicine, Ann Arbor, Michigan
Received 6 May 2008; Accepted 17 October 2009
Mutations in GJB2, encoding connexin 26 (Cx26), cause both
autosomal dominant and autosomal recessive nonsyndromic
hearing loss (ARNSHL) at the DFNA3 and DFNB1 loci, respec-
tively. Most of the over 100 described GJB2 mutations cause
ARNSHL. Only a minority has been associated with autosomal
dominant hearing loss. In this study, we present two families
with autosomal dominant nonsyndromic hearing loss caused by
a novel mutation in GJB2 (p.Asp46Asn). Both families were
ascertained from the same village in northern Iran consistent
with a founder effect. This finding implicates the D46N missense
mutation in Cx26 as a common cause of deafness in this part of
Iran mandating mutation screening of GJB2 for D46N in all
persons with hearing loss who originate from this geographic
region.  2011 Wiley-Liss, Inc.
Key words: connexin 26; D46N; autosomal dominant nonsyn-
dromic hearing loss; DFNA3; Iran
INTRODUCTION
Approximately one in 1,000 newborns has severe-to-profound
hearing loss and in more than half of this group of babies the
etiology is genetic [Smith et al., 2005]. The pattern of inheritance is
most frequently autosomal recessive, while autosomal dominant,
X-linked and mitochondrial inheritances occur less frequently.
Mutations in one gene, GJB2, have been found to cause up to half
of autosomal recessive nonsyndromic hearing loss (ARNSHL) cases
in developed countries [Estivill et al., 1998; Kelley et al., 1998; Green
et al., 1999].
GJB2 encodes connexin 26 (Cx26), a member of a highly
conserved protein family found throughout the animal kingdom
[van Steensel et al., 2004a]. Six connexins oligomerize to form pore-
like plasma membrane hemichannels called connexons. Connexons
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in adjacent cells then align to form gap junction channels, which
facilitate electrical and biochemical coupling between cells. Al-
though the function of gap junction channels in the inner ear has
not been definitively determined, a role in maintaining cochlear
homeostasis by recycling Kþ ions following hair cell depolarization
has been postulated [Kikuchi et al., 1995].
The majority of the over 100 deafness-causing mutations de-
scribed in GJB2 causes ARNSHL, however 29 GJB2 mutations have





affecteds Phenotype Refs.cDNA level
Protein
level
c.131G > C W44S E1 — Nonsyndromic http://davinci.crg.es/deafness/index.
php?seccion¼mut_db&db¼
nonsynd&nonsynd¼cx26mut
c.132G > C W44C E1 2 French families Nonsyndromic Denoyelle et al. [1998]
c.223C > T R75W M2 — Nonsyndromic Janecke et al. [2001]; Mani et al.
[2008]
c.224G > A R75Q M2 4 Nonsyndromic http://davinci.crg.es/deafness/
index.php?seccion¼mut_db&db¼
nonsynd&nonsynd¼cx26mut
c.428G > A R143Q M3 1 Austrian family Nonsyndromic L€offler et al. [2001]
c.487A> C M163L E2 Nonsyndromic Matos et al. [2008]




c.551G > A R184Q E2 — Nonsyndromic Hamelmann et al. [2001]
c.605G > T C202F M4 A large French family Nonsyndromic Morle et al. [2000]
c.34G> C G12R NT 1 Syndromic (keratitis-ichthyosis-deafness) Richard et al. [2002]
c.42C> G N14K NT 1 Hypotrichosis-deafness van Steensel et al. [2004b]
c.40A> C N14Y NT 1 Syndromic (keratitis-ichthyosis-deafness) Arita et al. [2006]
c.50C> T S17F NT 1 Syndromic (keratitis-ichthyosis-deafness) Richard et al. [2002]
c.119C > T A40V M1 1 Syndromic (keratitis-ichthyosis-deafness
and the follicular occlusion triad)
Montgomery et al. [2004]
125_127delAGG E42del M1 1 family Syndromic (palmoplantar keratoderma
with deafness)
Rouan et al. [2001]
c.134G > A G45E E1 — Syndromic (Keratitis-Ichthyosis-Deafness) Janecke et al. [2005
]; Jonard et al. [2008]
c.148G > A D50N E1 7 Syndromic (keratitis-ichthyosis-deafness;
hystrix-like ichthyosis-deafness)
van Steensel et al. [2002]
c.148G > T D50Y E1 1 Syndromic (keratitis-ichthyosis-deafness) Yotsumoto et al. [2003]
c.160A> C N54H E1 1 Syndromic (Bart-Pumphrey) Akiyama et al. [2007]
not described N54K E1 1 family Syndromic (Bart-Pumphrey) Richard et al. [2000]
c.175G > C G59R E1 1 Syndromic (palmoplantar keratoderma
with deafness)
Leonard et al. [2005]
c.175G > A G59S E1 1 Syndromic (palmoplantar keratoderma
with deafness)
Alexandrino et al. [2005]
c.176C > G G59A E1 1 family Syndromic (palmoplantar keratoderma
with deafness)
Heathcote et al. [2000]
c.196G > C D66H E1 10 Syndromic (Vohwinkel) Maestrini et al. [1999]
c.219A> G H73R M2 1 family Syndromic (palmoplantar keratoderma
with deafness)
de Zwart-Storm et al. [2008b]
c.223C > T R75W M2 — Syndromic (palmoplantar keratoderma
with deafness)
Richard et al. [1998];
Yuan et al. [2009]
c.224G > A R75Q E1 1 Turkish family Syndromic (palmoplantar keratoderma
with deafness)
Uyguner et al. [2002]
c.389G > T G130V CL 1 family Syndromic (Vohwinkel) Snoeckx et al. [2005]
c.424T> C F142L M3 1 Syndromic (mucositis-deafness) Brown et al. [2003]
c.548C > T S183F E2 1 family Syndromic (palmoplantar keratoderma
with deafness)
de Zwart-Storm et al. [2008a]
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been associated with autosomal dominant hearing loss (ADHL)
(Table I). About two-thirds of these mutations cause a syndrome in
which hearing loss is associated with distinct skin manifestations.
Examples of these syndromes include Keratitis-Ichthyosis-
Deafness (KID) syndrome [MIM 148210], Vohwinkel syndrome
[MIM 124500], Bart-Pumphrey syndrome [MIM 149200], and
palmoplantar keratoderma (PPK) with deafness [MIM 148350].
The remaining one-third of dominant GJB2 mutations causes
autosomal dominant nonsyndromic hearing loss (ADNSHL). In
this study, we present a novel GJB2 mutation responsible for
ADNSHL in two families from a village in northern Iran.
MATERIALS AND METHODS
Subjects
This study was approved by the Institutional Review Boards of the
University of Social Welfare and Rehabilitation Sciences in Tehran,
Iran and the University of Iowa, Iowa City, IA, United States.
FIG. 1. A: Pedigrees of two families, L-1301 (upper pedigree) and L-3057 (lower pedigree) with hearing loss caused by a novel mutation in GJB2, D46N.
The proband of each family is indicated by an arrow. All individuals who did not have audiograms are indicated with an asterisk. Studied branches are
shown with capital letters. B: All genotypes are indicated on pedigrees beneath the studied individuals.
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Informed consent was obtained from all family members wishing to
participate in this research. For each consenting person, clinical
assessment and genetic counseling were performed. Audiometric
testing was performed by measuring air and bone conduction
thresholds.
Haplotyping
Genomic DNA was isolated from peripheral blood using estab-
lished techniques [Miller et al., 1988] and used to complete
haplotype reconstruction for microsatellite markers that map to
chromosome 13q12, the genomic region that includes GJB2.
Markers were PCR amplified and products were resolved on the
ABI Prism 3130 Genetic Analyzer. Alleles were assigned using
GeneMapper 3.0 software (Applied Biosystems, Inc., Foster city,
CA), with haplotypes reconstructed using custom-made software.
GJB2 Screening
Mutation screening was completed on an Applied Biosystems (ABI)
model 3700 automated sequencer. Sequence data were compared to
published sequence for GJB2 using the Sequencher 4.1.2 software
program package (Gene Codes, MI, Ann Arbor, MI). The putative
structural and functional significance of observed mutations was
assessed using the ConSeq web server (http://conseq.tau.ac.il/).
Conseq scores obtained using this alignment method range from 1
(variable) to 9 (conserved).
RESULTS
Subjects
Family members from two families, L-1301 and L-3057, segregating
ADNSHL were recruited for this study (Fig. 1). Although most
persons consented to participate, some individuals (shown with
asterisk in Fig. 1) declined to have audiograms taken. For those
persons with hearing loss, audiometry confirmed the loss to be
sensorineural. Figure 2 shows hearing thresholds for the better
hearing ear in six persons from family L-1301 and in four persons
from family L-3057. In most persons, the hearing loss was
postlingual with an onset in the first decade, however VI:13 and
VI:9 had prelingual hearing loss that quickly progressed to become
severe to profound in VI:13 (Fig. 2: L-1301:1 and L-1301:2).
Intrafamilial variation was observed (Fig. 2). Pure tone audiograms
by age group are shown in Figure 3. No features of syndromic
hearing loss were observed in any person with hearing loss in these
families (Fig. 4).
FIG. 1. (Continued)
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Haplotype Analysis and Mutation Screening
Haplotype reconstruction was consistent with linkage to the
DFNA3 locus on chromosome 13q12. Mutation analysis of GJB2
identified a novel mutation, 351G>A, in affected subjects (Fig. 1).
This missense mutation replaces the acidic aspartate residue at
position 46 with the neutral asparagine residue (D46N). The
mutation was not present in nonaffected family members and was
similarly absent in 200 Iranian control samples. D46 is located in the
first extracellular loop (E1) of Cx26, a region known to be highly
conserved among connexin family members and to play an
important role in voltage gating and in facilitating docking
between opposing connexons [Rubin et al., 1992; White et al.,
1995; Martin and Evans, 2004; Mese et al., 2007]. The ConSeq
alignment confirmed conservation of this amino acid in multiple
species (ConSeq score¼ 9; Fig. 5). Based on these data, D46N is
believed to be the disease-causing mutation in both families segre-
gating ADNSHL.
FIG. 1. (Continued)
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FIG. 1. (Continued)
FIG. 2. Audiograms associated with GJB2 D46N hearing loss (better
hearing ear is shown). Top: Sequential audiograms from two
persons in family L-1301 showing progression to severe-to-
profound hearing loss. Middle: Audiograms from five persons in
family L-1301 at different ages showing relatively uniform
audioprofiles. Bottom: Audiograms from four persons in family
L-3057 at different ages showing variably in hearing thresholds by
age.
FIG. 3. Audioprofiles showing average audiograms by age group for
both families.
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DISCUSSION
In this report we present two families with ADNSHL caused by a
novel amino acid change—D46N—in GJB2. To date, 9 mutations
in GJB2 have been linked to ADNSHL whilst 21 mutations cause
syndromic hearing loss associated with a variety of skin diseases.
Two mutations, R75W and R75Q, cause both syndromic and
nonsyndromic hearing loss.
Most of the known dominant mutations, whether syndromic
and nonsyndromic, occur in the highly conserved first extracellular
loop (E1) of Cx26, which is crucial for voltage gating and connexon-
–connexon docking (Fig. 6) [Richard et al., 2002; Martin and Evans,
2004]. Prominent among these mutations are G45E, D50N, and
D50Y, which cause KID syndrome [Richard et al., 2002; Sonoda
et al., 2004; Janecke et al., 2005; OMIM 148210], and W44C and
W44S, which cause ADNSHL [Denoyelle et al., 1998; Tekin et al.,
2001; Marziano et al., 2003; MIM 601544]. The D46N mutation
affects the same region of E1 (Fig. 6). The recently resolved crystal
structure of a Cx26 gap junction channel has shown that this
segment of E1 forms a 310 helix structure which lines the channel
pore [Maeda et al., 2009].
Many mutations in GJB2 that cause ARNSHL cause a simple loss-
of-channel activity, however it is less clear how dominant mutations
affect gap junction function [Bruzzone et al., 2001]. The broad
phenotypic heterogeneity seen with autosomal dominant muta-
tions suggests variability in the molecular defects caused by indi-
vidual mutations. For example, some dominant GJB2 mutations,
like R75W, are known to inhibit formation of functional channels.
Expression studies in Xenopus oocytes have shown that R75W,
which occurs in a highly conserved region involved in voltage
gating, inhibits normal gap junction function of co-expressed wild-
type Cx26 in a dominant-negative manner [Richard et al., 1998].
Dye transfer studies using the gap junction permeant tracer Cascade
Blue have also demonstrated a disruption of intercellular coupling
with W44S, R75W, G59A, and D66H. For G59A and D66H
mutants, this change correlates with impaired intracellular traffick-
ing and targeting to the plasma membrane [Marziano et al., 2003].
Functional studies also indicate that the mutation T55N produces a
protein that is deeply impaired in its intracellular trafficking and
fails to reach the plasma membrane [Melchionda et al., 2005].
Although functional studies of D46N are needed to determine
the effect of this mutation on channel activity, useful information
can be gleaned by studying the structure of wild-type Cx26 gap
junction channels. Based on the structural analysis by Maeda and
coworkers, D46 is one of the key residues involved in interactions
between adjacent connexins. Additionally, D46 and D50 line the
gap junction pore at the level of the cell membrane and face the
interior of the channel, creating a negatively charged path between
adjacent cells [Maeda et al., 2009]. This region is hypothesized to
contribute to charge selectivity and size restriction of the gap
junction. While the size of the side chain would not be significantly
altered, the D46N mutation would reduce the negative charge,
potentially altering the permselectivity of the channel.
The strong evolutionary conservation of D46 between species
and among connexins, its location lining the pore of the Cx26 gap
junction, the predicted importance of its negative charge, and its
absence in 200 Iranian control subjects are convincing evidence for
the disease-causing effect of this mutation. The identification of this
mutation in two families from the same small village in northern
Iran is consistent with a founder effect, which we confirmed by
genotyping additional microsatellite markers in the DFNB1 region.
On this basis, we recommend screening for this mutation in deaf
persons from the Northern provinces in Iran.
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FIG. 5. Multiple sequence alignment of the first extracellular loop (E1) of connexin 26 shows high cross-species conservation (D46 indicated
by arrow).
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